Skip to main content
H.R. 1082 119th Congress House

Shandra Eisenga Human Cell and Tissue Product Safety Act

Official title: To require the Secretary of Health and Human Services to conduct a national, evidence-based education campaign to increase public and health care provider awar… Show full official titleShow less

Official title: To require the Secretary of Health and Human Services to conduct a national, evidence-based education campaign to increase public and health care provider awareness regarding the potential risks and benefits of human cell and tissue products transplants, and for other purposes.

Introduced: February 6, 2025 Introduced by: John R. Moolenaar Republican · Michigan See on congress.gov
Health Administrative law and regulatory proceduresCivil actions and liabilityCongressional oversightDepartment of Health and Human Services
More subjectsShow fewer subjects
Health programs administration and fundingHealth promotion and preventive careOrgan and tissue donation and transplantation
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 13 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 24, 2025
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jun 23, 2025
Motion to reconsider laid on the table Agreed to without objection.
Jun 23, 2025
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H2860-2861)
Jun 23, 2025
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H2860-2861)
Jun 23, 2025
DEBATE - The House proceeded with forty minutes of debate on H.R. 1082.
Jun 23, 2025
Considered under suspension of the rules. (consideration: CR H2860-2862)
Jun 23, 2025
Mr. Bilirakis moved to suspend the rules and pass the bill.
Jun 12, 2025
Reported by the Committee on Energy and Commerce. H. Rept. 119-160.
Jun 12, 2025
Placed on the Union Calendar, Calendar No. 127.
Apr 29, 2025
Ordered to be Reported by Voice Vote.
Apr 29, 2025
Committee Consideration and Mark-up Session Held
Feb 6, 2025
Referred to the House Committee on Energy and Commerce.
Feb 6, 2025
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

What's happening now June 24, 2025

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Plain-English summary Congressional Research Service

Shandra Eisenga Human Cell and Tissue Product Safety Act

This bill establishes civil penalties for violations of regulations governing the donation and handling of human cell and tissue products. It also requires the Food and Drug Administration (FDA) to report on the regulation of these products and to provide related information to stakeholders. (Human cell and tissue products are articles containing or consisting of human cells or tissues that are intended for use in a human recipient.)

Specifically, the bill establishes civil penalties for violations of the FDA’s regulations on donor eligibility and current good tissue practice for manufacturing and distributing human cell and tissue products.

Also, the bill requires the FDA to conduct workshops to educate stakeholders and facilitate discussion on the science and regulation of human cell and tissue products. The FDA must establish a public docket to receive written comments on this topic, and report to Congress with recommendations. The bill also requires the FDA to support the development of educational materials for health care professionals regarding organ, tissue, and eye donations and related topics.

Additionally, the bill requires the FDA to publish on its website educational materials about the Tissue Reference Group (a working group within the FDA) and best practices for obtaining a recommendation from them about human cell and tissue products. Also, annually for three years, the FDA must publish on its website information on inquiries submitted to the Tissue Reference Group and FDA registrations and inspections regarding human cell and tissue manufacturers. 

 Hearings & markups 2
  • Markup of 6 Bills
    Markup Apr 29, 2025 · 10:00 AM EDT · Energy and Commerce Committee
  • Markup of 26 Bills
    Markup Rescheduled Apr 8, 2025 · 10:15 AM EDT · Energy and Commerce Committee
 Related & companion bills 1
  • HR 340 The HCT/P Modernization Act of 2025
 Bill text 4 versions

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Lobbying activity 10

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

  • UNIVERSITY OF MICHIGAN
    for UNIVERSITY OF MICHIGAN · District of Columbia · 3rd Quarter 2026 (July 1 - Sep 30)
  • UNIVERSITY OF MICHIGAN
    for UNIVERSITY OF MICHIGAN · District of Columbia · 2nd Quarter 2026 (Apr 1 - June 30)
  • UNIVERSITY OF MICHIGAN
    for UNIVERSITY OF MICHIGAN · District of Columbia · 1st Quarter 2026 (Jan 1 - Mar 31)
  • UNIVERSITY OF MICHIGAN
    for UNIVERSITY OF MICHIGAN · District of Columbia · 4th Quarter 2025 (Oct 1 - Dec 31)
  • UNIVERSITY OF MICHIGAN
    for UNIVERSITY OF MICHIGAN · District of Columbia · 3rd Quarter 2025 (July 1 - Sep 30)
  • SUSAN B ANTHONY LIST
    for SUSAN B ANTHONY LIST · Virginia · 3rd Quarter 2025 (July 1 - Sep 30)

Bodies those filers lobbied

A filing lists the bills it worked on and the parts of government it contacted in separate sections, so these are the bodies those filers named anywhere in the filing, not a per-bill breakdown.

See all 10 filings →
 Cosponsors 1
All 1 Democratic 1
D
Dingell, Debbie
Michigan · Feb 6, 2025
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 1082: Shandra Eisenga Human Cell and Tissue Product Safety Act. 119th Congress. Open America. https://openamerica.io/bill/119-HR-1082/
MLA
"H.R. 1082: Shandra Eisenga Human Cell and Tissue Product Safety Act." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-HR-1082/.
Bluebook (legal)
H.R. 1082, 119th Cong. (2026), https://openamerica.io/bill/119-HR-1082/.
Markdown link
[H.R. 1082: Shandra Eisenga Human Cell and Tissue Product Safety Act](https://openamerica.io/bill/119-HR-1082/)
Report a problem